Status:
UNKNOWN
Lactobacillus Reuteri DSM 17938 and Prevention of Respiratory and Gastrointestinal Infections in Mexican Infants
Lead Sponsor:
National Institute of Pediatrics, Mexico
Conditions:
Healthy Infants
Eligibility:
All Genders
6-36 years
Phase:
PHASE3
Brief Summary
Randomized, doble blind, clinical, controlled trial aimed to investigate the role of Lactobacillus reuteri DSM 17938 in the prevention of gastrointestinal and respiratory tract infections in mexican c...
Eligibility Criteria
Inclusion
- Healthy infants
- Born at term (≥36 weeks of gestation)
- Any gender
- 6 to 36 months old
- Same socioeconomic background
- Written informed consent from parents or legal guardians
Exclusion
- Birth weight \<2500 g
- Congenital anomalies
- Chronic diseases
- Failure to thrive
- Allergy or atopic disease
- Recent (within the preceding 4 weeks) exposure to probiotics, prebiotics, or antibiotics.
- Concurrent participation in other clinical trials
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2011
Estimated Enrollment :
269 Patients enrolled
Trial Details
Trial ID
NCT01249911
Start Date
January 1 2011
End Date
June 1 2011
Last Update
November 30 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.